Cancer Communications
indexed by SCI
BMC


ORIGINAL ARTICLE
Pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD-3 study
Maja Nik?i?, Pamela Minicozzi, Hannah K Weir, Heather Zimmerman, Maria J Schymura, Judith R Rees, Michel P Coleman, Claudia Allemani, US CONCORD Working Group
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/9/2022   doi:10.1002/cac2.12375
RESEARCH HIGHLIGHT
Lymphatic metastasis in non-small cell lung cancer: recent discoveries and novel therapeutic targets
Xiayao Diao, Chao Guo, Shanqing Li
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/9/2022   doi:10.1002/cac2.12378
ORIGINAL ARTICLE
Cytosolic TGM2 promotes malignant progression in gastric cancer by suppressing the TRIM21-mediated ubiquitination/degradation of STAT1 in a GTP binding-dependent modality
Lu Zhang, Qingya Li, Jing Yang, Penghui Xu, Zhe Xuan, Jianghao Xu, Zekuan Xu
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/9/2022   doi:10.1002/cac2.12386
ORIGINAL ARTICLE
Elevated neutrophil extracellular traps by HBV-mediated S100A9-TLR4/RAGE-ROS cascade facilitate the growth and metastasis of hepatocellular carcinoma
Xi Zhan, Rui Wu, Xue-Hua Kong, Yan You, Kun He, Xiao-Yu Sun, Yong Huang, Wei-Xian Chen, Liang Duan
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/8/2022   doi:10.1002/cac2.12388
ORIGINAL ARTICLE
Sintilimab versus docetaxel as second-line treatment in advanced or metastatic squamous non-small-cell lung cancer: an open-label, randomized controlled phase 3 trial (ORIENT-3)
Yuankai Shi, Lin Wu, Xinmin Yu, Puyuan Xing, Yan Wang, Jianying Zhou, Airong Wang, Jianhua Shi, Yi Hu, Ziping Wang, Guangyu An, Yong Fang, Sanyuan Sun, Caicun Zhou, Changli Wang, Feng Ye, Xingya Li, Junye Wang, Mengzhao Wang, Yunpeng Liu, Yanqiu Zhao, Yin
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/6/2022   doi:10.1002/cac2.12385
LETTER TO THE EDITOR
Lysosomal TMEM9-LAMTOR4-controlled mTOR signaling integrity is required for mammary tumorigenesis
Shengzhe Zhang, Sung Ho Lee, Litong Nie, Yuanjian Huang, Gengyi Zou, Youn-Sang Jung, Sohee Jun, Jie Zhang, Esther M. Lien, Junjie Chen, Jae-Il Park
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/6/2022   doi:10.1002/cac2.12382
LETTER TO THE EDITOR
Detection of piRNA-54265 in human serum: evidence and significance
Dongmei Mai, Ying Ye, Lisha Zhuang, Jian Zheng, Dongxin Lin
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/6/2022   doi:10.1002/cac2.12381
LETTER TO THE EDITOR
Novel endogenous endoplasmic reticulum transmembrane protein SURF4 suppresses cell death by negatively regulating the STING-STAT6 axis in myeloid leukemia
Jayoung Kim, Hansong Lee, Chae Mi Hong, Ji Ho Nam, Hye Ju Yeo, Woo Hyun Cho, Hyung-Sik Kim, Changwan Hong, Yun Hak Kim, Dongjun Lee
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/6/2022   doi:10.1002/cac2.12390
LETTER TO THE EDITOR
p21 is necessary for the beneficial effects of fasting during chemotherapy
Adrián Plaza, Andrés Pastor-Fernández, José L. López-Aceituno, Marta Barradas, Cristina Pantoja, Pablo J. Fernandez-Marcos
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/4/2022   doi:10.1002/cac2.12384
ORIGINAL ARTICLE
Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non-small-cell lung cancer characterizes the features of response to PD-1 blockade plus chemotherapy
Fengying Wu, Tao Jiang, Gongyan Chen, Yunchao Huang, Jianying Zhou, Lizhu Lin, Jifeng Feng, Zhehai Wang, Yongqian Shu, Jianhua Shi, Yi Hu, Qiming Wang, Ying Cheng, Jianhua Chen, Xiaoyan Lin, Yongsheng Wang, Jianan Huang, Jiuwei Cui, Lejie Cao, Yunpeng Liu
Cancer Communications 2022 42:
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/4/2022   doi:10.1002/cac2.12383

<<    Page 2 of 56  >>    




CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China